Local recurrence after curative resection of early gastric cancer by endoscopic submucosal dissection.

Authors

null

Moon Kyung Joo

Korea University Guro Hospital, Korea University College of Medicine, Seoul, South Korea;

Moon Kyung Joo , Jong-Jae Park , Beom Jae Lee , Sunsuk Kim , Hoon Jai Chun

Organizations

Korea University Guro Hospital, Korea University College of Medicine, Seoul, South Korea; , Korea University Guro Hospital Healthcare System, Seoul, South Korea; , Korea University Anam Hospital, Korea University College of Medicine, Seoul, South Korea;

Research Funding

No funding received
None.

Background: We investigate the local recurrence rate and its risk factors among patients who underwent endoscopic submucosal dissection (ESD) for early gastric cancer (EGC) and are judged as curative resection. Methods: We enrolled patients who were diagnosed as EGC and underwent ESD during 2006 and 2020. Local recurrence after ESD was confirmed by histopathologic evaluation by endoscopic biopsy at ESD site during endoscopic surveillance. Results: A total of 936 patients underwent ESD for EGC, achieved curative resection and were followed up more than 12 months. Among them, 14 cases of local recurrence were found (14/936, 1.5%) during 53.2 months of follow-up. Compared with patients without local recurrence, those with local recurrence showed male-predominance (677/922 vs. 14/14, P=0.025), frequent presence of synchronous tumor (123/922 vs. 6/14, P=0.001) and larger tumor size (16.3 vs. 26.3 mm, P=0.001). Kaplan-Meier graph also showed that local recurrence significantly occurred in subgroup with male, presence of synchronous tumor and tumor size ≥ 20 mm (P=0.028, 0.009 and <0.001 by log rank test, respectively). After propensity score matching for gender, age and comorbidities with 1:5 ratio, tumor size ≥ 20 mm was the only significant factor for local recurrence (odds ratio: 3.886, 95% confidence interval: 1.012-14.922, P=0.048) Conclusions: Endoscopists need to be cautious for local recurrence at ESD site even after curative resection of EGC, especially for large tumor size.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cancers of the Esophagus and Stomach and Other GI Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Therapeutics

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr 388)

DOI

10.1200/JCO.2023.41.4_suppl.388

Abstract #

388

Poster Bd #

G10

Abstract Disclosures

Similar Abstracts

First Author: Tae-Se Kim

Abstract

2024 ASCO Gastrointestinal Cancers Symposium

Gastric microbiome signature to predict metachronous recurrence after endoscopic resection of gastric neoplasms.

First Author: Hokyoung Lee

Abstract

2024 ASCO Gastrointestinal Cancers Symposium

Clinical outcomes of early gastric cancer resected by endoscopic submucosal dissection at young age.

First Author: Jong-Jae Park